Gregory Murphy

2.5k citations
23 papers · 2.2k · 1 hit paper · h-index 14

Impact in

    • Peroxisome Proliferator-Activated Receptors
    • Wnt/β-catenin signaling in development and cancer
    • Metabolism, Diabetes, and Cancer
    • Cancer-related gene regulation
    • Receptor Mechanisms and Signaling

Papers in

    • Metabolism, Diabetes, and Cancer 5
    • Peroxisome Proliferator-Activated Receptors 5
    • Genomics, phytochemicals, and oxidative stress 2
    • Wnt/β-catenin signaling in development and cancer 2
    • Protein Kinase Regulation and GTPase Signaling 2
    • Pancreatic function and diabetes 5

Gregory Murphy

21 papers receiving 2.2k citations

Gregory Murphy's Hit Papers

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription 2000 · 792 citations
7920+8+17Years since publication250500750

Peers

Gregory Murphy
Comparison fields: 5 of 102
  • Molecular Biology 1.6k
  • Biochemistry 118
  • Endocrinology, Diabetes and Metabolism 215
  • Pharmacology 205
  • Cellular and Molecular Neuroscience 230
Replace Shivendra D. Shukla with:
Shivendra D. Shukla United States
Dominique Stengel France
Antoine Bril France
Erwin J. Landon United States
Imran N. Mungrue United States
Julien Hanson Belgium
Dipanjan Chanda South Korea
Chakkodabylu S. Ramesha United States
Yoshinori Asaoka Japan
Mark D. Leibowitz United States
Gregory Murphy relative to Shivendra D. Shukla United States Shivendra D. Shukla's profile →
Citations per field
00.5×1.5×
Shivendra D. Shukla · 1×
Citations per year

Countries citing papers authored by Gregory Murphy

Since Specialization
Citations

This map shows the geographic impact of Gregory Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Murphy more than expected).

Fields of papers citing papers by Gregory Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Murphy. The network helps show where Gregory Murphy may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory Murphy Line = papers co-authored together Gregory Murphy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
Hit paper breakdown →
2000792
2 1986342
3 2000332
4
Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.
1998211
5 199893
6 200493
7 200186
8 198980
9 200163
10 200343
11 199339
12 200118
13 198715
14 198913
15 19933
16 19942
17
Confidential U.S. State Department central files, Iran, 1955-1959 : internal affairs, decimal numbers 788, 888, and 988, and foreign affairs, decimal numbers 688 and 611.88 [microform]
19911
18
Confidential U.S. State Department central files, Mexico, 1945-1949 : internal affairs
19871
19
Evidence-Based Adequacy Model for School Funding: Success Rates in Illinois Schools that Meet Targets.
20121
20 19901

About Gregory Murphy

Gregory Murphy is a scholar working on Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism, Pharmacology and Cell Biology, having authored 23 papers that have together received 2.2k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Pancreatic function and diabetes (5 papers), Inflammatory mediators and NSAID effects (4 papers), Diabetes Treatment and Management (4 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Molecular Biology (1.6k citations), Biochemistry (118 citations), Endocrinology, Diabetes and Metabolism (215 citations), Pharmacology (205 citations) and Cellular and Molecular Neuroscience (230 citations). Gregory Murphy has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Julie C. Holder, Miles D. Houslay, Michael J.O. Wakelam, Victor J. Hruby, David Haigh, Stacey L. Corcoran, Matthew P. Coghlan, John Yates, Stephen A. Smith and Paul S. Carter. Their work appears in journals such as Biochemical Journal, Biochemical Society Transactions, Metabolism, Biochemical Pharmacology and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact